These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 4064147)
1. [Sydnocarb as the method of choice in persistent enuresis? Findings after 2 years of administration]. Simlová M; Vocásek Z Cesk Psychiatr; 1985 Oct; 81(5):312-3. PubMed ID: 4064147 [No Abstract] [Full Text] [Related]
2. Treatment of enuresis with sydnocarb. Polák L; Skoricová M; Dimová N; Havlícková H; Okruhlica L; Molcan J Act Nerv Super (Praha); 1981 Dec; 23(4):263-4. PubMed ID: 7336856 [No Abstract] [Full Text] [Related]
3. [Experience with the use of sidnocarb in child psychiatry]. Linka Z Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):278-80. PubMed ID: 1119270 [No Abstract] [Full Text] [Related]
4. Proceedings: Clinical experience with sydnocarb in neuroses and psychoses. Zapletálek M; Hubsch T; Kindernayová H Act Nerv Super (Praha); 1975; 17(4):235-6. PubMed ID: 3934 [No Abstract] [Full Text] [Related]
5. [Experience with new psychostimulant - Sydnocarb]. Bach O; Petermann H; Heber I Psychiatr Neurol Med Psychol (Leipz); 1976 Oct; 28(10):609-14. PubMed ID: 798218 [No Abstract] [Full Text] [Related]
6. [Clinical and electroencephalographic features of the action of the psychic stimulant sydnocarb in various forms of epilepsy]. Biniaurishvili RG; Veĭn AM; Chalkov VG Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(6):886-91. PubMed ID: 6431728 [TBL] [Abstract][Full Text] [Related]
7. [Sidnocarb treatment of young schoolchildren with the hyperdynamic syndrome]. Krasov VA Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(8):97-101. PubMed ID: 3195293 [TBL] [Abstract][Full Text] [Related]
8. EEG changes after mesocarb in respondent and nonrespondent hyperkinetic children. Drtílková I; Misurec J; Balastíková B; Náhunek K; Výborová L; Sindelárová M Act Nerv Super (Praha); 1989 Apr; 31(1):50. PubMed ID: 2782000 [No Abstract] [Full Text] [Related]
9. [Effect of psychotropic substances on the physical work capacity of animals under high and low temperature conditions]. Liubimov BI; Ostrovskaia GZ Farmakol Toksikol; 1977; 40(2):133-6. PubMed ID: 856624 [TBL] [Abstract][Full Text] [Related]
10. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy]. Strasser R; Klepzig H; Ostrowski J; Resag K MMW Munch Med Wochenschr; 1983 Feb; 125(8):156-8. PubMed ID: 6405248 [No Abstract] [Full Text] [Related]
11. [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris]. Jasiński K; Lukasik S; Poprawski K; Wrabec K; Nowosad H; Kargul W Kardiol Pol; 1981; 24(5):397-405. PubMed ID: 7021947 [No Abstract] [Full Text] [Related]
12. [Hemodynamic effects of molsidomine in chronic cardiac decompensation]. Hoffmann E; Traina M; Alfano R; Piraino GL; Raineri A Boll Soc Ital Cardiol; 1981; 26(11):1485-92. PubMed ID: 6897512 [No Abstract] [Full Text] [Related]
13. [Clinical evaluation of molsidomin in ischemic cardiopathy]. Di Giacomo G; Nicolella U; Puligheddu M; Tripodi A; D'Ascoli C; Di Virgilio D Clin Ter; 1984 Oct; 111(2):141-6. PubMed ID: 6239736 [No Abstract] [Full Text] [Related]
14. [Use of molsidomine in patients with coronary disease]. Goch JH; Rosiek S; Brzozowski R; Bała T; Tkaczewski W; Adamska-Dyniewska H Pol Tyg Lek; 1985 Jul; 40(29):829-31. PubMed ID: 3903695 [No Abstract] [Full Text] [Related]
15. [Comparative hemodynamic studies with molsidomine and isosorbide dinitrate after aortocoronary bypass]. Fritz KW; Eglins P; Höge B; Hehrlein FW; Lüllwitz E; Kirchner E Intensivmed Prax; 1982 Jun; 5():27-38. PubMed ID: 6984020 [No Abstract] [Full Text] [Related]
16. [Comparative study of the anti-angina drug korvatone (molsidomin) and organic nitrates]. Komarov FI; Ol'binskaia LI; Vartanova OA; Bragina GI; Ovchinnikova LV Klin Med (Mosk); 1980 Aug; 58(8):55-60. PubMed ID: 6774161 [No Abstract] [Full Text] [Related]